408 related items for PubMed ID: 11793859
1. Cyclosporin A treatment for idiopathic membranous nephropathy.
Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.
Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
[Abstract] [Full Text] [Related]
2. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[Abstract] [Full Text] [Related]
3. Cyclosporine A in treatment of membranous lupus nephropathy.
Hu W, Liu Z, Shen S, Li S, Yao X, Chen H, Li L.
Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467
[Abstract] [Full Text] [Related]
4. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
5. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ, Wetzels JF.
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[Abstract] [Full Text] [Related]
6. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
Tao JL, Liu LL, Wen YB, Gao RT, Li H, Li MX, Li XM, Li XW.
Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
[Abstract] [Full Text] [Related]
7. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[Abstract] [Full Text] [Related]
8. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[Abstract] [Full Text] [Related]
9. Effective treatment administration of cyclophosphamide in membranous nephropathy.
Dede F, Ayili D, Sahiner S.
J Nephrol; 2008 May; 21(4):560-5. PubMed ID: 18651546
[Abstract] [Full Text] [Related]
10. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
Am J Nephrol; 2007 May; 27(3):226-31. PubMed ID: 17389782
[Abstract] [Full Text] [Related]
11. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Naumovic R, Jovanovic D, Pavlovic S, Stosovic M, Marinkovic J, Basta-Jovanovic G.
Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
[Abstract] [Full Text] [Related]
12. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF.
Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912
[Abstract] [Full Text] [Related]
13. [Curative effects of cyclosporin A therapy upon myelodysplastic syndrome].
Chen SC, Jiang B, Da WM, Gong M, Guan M.
Zhonghua Yi Xue Za Zhi; 2006 Oct 17; 86(38):2711-5. PubMed ID: 17199984
[Abstract] [Full Text] [Related]
14. Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.
McQuarrie EP, Stirling CM, Geddes CC.
Nephrol Dial Transplant; 2012 Jan 17; 27(1):235-42. PubMed ID: 21558430
[Abstract] [Full Text] [Related]
15. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
Frassinetti Castelo Branco Camurça Fernandes P, Bezerra Da Silva G, De Sousa Barros FA, Costa Oliveira CM, Kubrusly M, Evangelista JB.
J Nephrol; 2005 Jan 17; 18(6):711-20. PubMed ID: 16358229
[Abstract] [Full Text] [Related]
16. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
Nephrol Dial Transplant; 2006 Nov 17; 21(11):3127-32. PubMed ID: 16968719
[Abstract] [Full Text] [Related]
17. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
Eriguchi M, Oka H, Mizobuchi T, Kamimura T, Sugawara K, Harada A.
Nephrol Dial Transplant; 2009 Oct 17; 24(10):3082-8. PubMed ID: 19465558
[Abstract] [Full Text] [Related]
18. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
Li X, Lv R, He Q, Li H, Du X, Lin W, Li Q, He X, Wang S, Chen J.
J Nephrol; 2008 Oct 17; 21(4):584-91. PubMed ID: 18651550
[Abstract] [Full Text] [Related]
19. Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine.
Mok CC, Ying KY, Yim CW, Ng WL, Wong WS.
Lupus; 2009 Oct 17; 18(12):1091-5. PubMed ID: 19762384
[Abstract] [Full Text] [Related]
20. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW, Wetzels JF.
Nephrol Dial Transplant; 2004 Aug 17; 19(8):2036-43. PubMed ID: 15187191
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
